News

Collaborative work of REGLYS Team

Innate immune mediators of pathogen clearance, including the secreted C-type lectins REG3 of the antimicrobial peptide (AMP) family, are known to be involved in the regulation of tissue repair and homeostasis. Their role in metabolic homeostasis remains unknown. Here the authors show that… Lire la suite Collaborative work of REGLYS Team

30th European Congress on Obesity

The 30th European Congress on Obesity takes place from 17-20 May 2023 in Dublin, Ireland Lire la suite 30th European Congress on Obesity

New review from IMMEDIAB Team

Type 2 diabetes (T2D) represents a global threat affecting millions of patients worldwide. However, its causes remain incompletely dissected and we lack the tools to predict which individuals will develop T2D.. Here, the authors propose that a significant proportion of individuals may harbor an immune profile that renders them susceptible to developing T2D. W Lire la suite New review from IMMEDIAB Team

New article from the team “Insulin signaling, glucose sensing and glucotoxicity”

Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction Lire la suite New article from the team “Insulin signaling, glucose sensing and glucotoxicity”

A review from Movassat team

Diabetes Mellitus is a metabolic disorder characterized by a chronic hyperglycemia due to an impaired insulin secretion and a decreased in peripheral insulin sensitivity. This disease is a major public health problem due to it sharp prevalence. Therefore, it is crucial to readapt therapeutic approaches for the treatment of this pathology. One of the strategies would be through P2-type purinergic receptors pathway via ATP binding. Lire la suite A review from Movassat team